Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theratechnologies Inc
T.TH
Alternate Symbol(s):
THTX
Healthcare
Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs...
in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5)
•••
Kalsabor
X
View Profile
View Bullboard History
Comment by
Kalsabor
on Jun 28, 2024 8:51am
RE:RE:RE:RE:RE:RE:RE:nice pop
I feel your pain....down 90% on GDNP
(182)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 28, 2024 7:19am
RE:RE:RE:RE:RE:RE:nice pop
Good to know... I bought at 20$ 30 years ago... congrats
(5)
•••
Kalsabor
X
View Profile
View Bullboard History
Comment by
Kalsabor
on Jun 28, 2024 6:28am
RE:RE:RE:RE:RE:nice pop
Anyone who bought at 1,25 probabably took profit...l know i should have. on the other hand anyone who bought at 2,20 will probably want some profit....we'll get back There
(182)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 27, 2024 2:58pm
RE:RE:RE:RE:RE:nice pop
Need a game changer to stop this gamestop nonsence and make a 10 bagger out of this dog... and take us back to... Brakeven.... lol
(182)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 27, 2024 2:11pm
RE:RE:RE:RE:nice pop
Whetever that was... pouet pouet... like the last time and the time before that....
(182)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 27, 2024 9:54am
RE:RE:RE:nice pop
Difficult to make anything about these moves. Is it a leak about next earnings. Why the sudden volume with no news. A lot of volume is from CIBC that if I'm not mistaken is the
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Jun 27, 2024 6:56am
Buzz on the Bullboards: Updates from Nevada Copper, BlackBerry, Tilray
The past week has been a roller-coaster ride for the TSX. Volatility was the theme as the market saw dramatic rises and falls.
read article.
(5)
•••
Kalsabor
X
View Profile
View Bullboard History
Comment by
Kalsabor
on Jun 26, 2024 1:03pm
RE:RE:nice pop
Thinking about dilution?? I think it's more expectation towards the financial.
(182)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 26, 2024 12:44pm
RE:nice pop
Hope it's something material. But I've seen this kind of pop just before they issued shares. Brokers do that sometimes to position the stock.
(277)
•••
palinc2000
X
View Profile
View Bullboard History
Post by
palinc2000
on Jun 26, 2024 12:33pm
nice pop
whatever the cause
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 26, 2024 7:30am
New Press Release - Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and...
read article.
(182)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 25, 2024 11:59am
RE:RE:RE:RE:Summary of published results to date
Forgot also that our bikers are working on value creation closer to year end. Kicking the can since 1933... and still going. Keeping in shape to drain the company some more.
(182)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 25, 2024 11:05am
RE:RE:RE:Summary of published results to date
What do we have to celebrate here. We have a steep 60M dept at 15% with shylocks. We have a promise of better sales in Q2 and FY2024. We have an ongoing P3 phase 1 on Th1902 that is never
...more
(182)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 25, 2024 10:13am
RE:RE:Summary of published results to date
Well they look happy on their bikes last time I looked at Linkedin. Also celebrating Quebec, I'm surprised about that.
(51)
•••
Qwerty54321
X
View Profile
View Bullboard History
Comment by
Qwerty54321
on Jun 22, 2024 8:17pm
RE:Summary of published results to date
They wouldn't be tinkering with the dose if the toxicity was fine. And if everything you said was true they'd be planning for Ph2 not still stuck in Ph1. The higher dose in part 3 is
...more
(98)
•••
Mannequin
X
View Profile
View Bullboard History
Post by
Mannequin
on Jun 22, 2024 6:29pm
Summary of published results to date
The results for TH1902 appear promising, particularly considering the challenging context of treating heavily pretreated patients with advanced solid tumors. Here are some key points to assess the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >